Skip to main content

Advertising Disclaimer »

Main menu

  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors
    • Submit Manuscript
    • Author Guidelines
  • Content
    • Current Issue
    • Complete Issue PDF
    • Archive
    • Topic/Program Collections
    • Blog
  • Multimedia
    • Teaching Slides
    • Pediatrics On Call Podcast
  • CME/MOC
    • CME Quizzes
    • MOC Claiming
  • Subscribe
  • Alerts
  • Careers
  • Other Publications
    • American Academy of Pediatrics

User menu

  • Log in

Search

  • Advanced search
American Academy of Pediatrics

AAP Gateway

Advanced Search

AAP Logo

  • Log in
  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors
    • Submit Manuscript
    • Author Guidelines
  • Content
    • Current Issue
    • Complete Issue PDF
    • Archive
    • Topic/Program Collections
    • Blog
  • Multimedia
    • Teaching Slides
    • Pediatrics On Call Podcast
  • CME/MOC
    • CME Quizzes
    • MOC Claiming
  • Subscribe
  • Alerts
  • Careers
American Academy of Pediatrics
Article

Inflammatory Bowel Disease

Jeffrey S. Hyams
Pediatrics in Review September 2000, 21 (9) 291-295; DOI: https://doi.org/10.1542/pir.21-9-291
Jeffrey S. Hyams
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • Comments
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Download PDF
  1. Jeffrey S. Hyams, MD*
  1. *Head, Division of Digestive Diseases and Nutrition, Connecticut Children’s Medical Center; Professor of Pediatrics, University of Connecticut School of Medicine, Hartford, CT. Dr Hyams is a Consultant, National Treatment Registry for Remicade for Centocor, Inc.

OBJECTIVES

After completing this article, readers should be able to:

  1. Describe the primary clinical difference between Crohn disease and ulcerative colitis.

  2. List the greatest single risk factor for developing inflammatory bowel disease.

  3. Delineate the primary presentation of children and adolescents who have Crohn disease.

  4. Explain the effects of prolonged daily use of high-dose corticosteroids.

  5. Describe the primary risk factor for intestinal cancer associated with both ulcerative colitis and Crohn disease.

Introduction

Inflammatory bowel disease (IBD) is a generic term used to describe two idiopathic disorders that are associated with gastrointestinal inflammation: Crohn disease (CD) and ulcerative colitis (UC). These disorders need to be distinguished from other conditions that may display similar clinical and laboratory findings, such as infection, allergy, and neoplasm. Because IBD also may be associated with a large array of extraintestinal manifestations, a knowledge of the clinical spectrum of these disorders is important to the clinician who may encounter associated pediatric problems such as growth delay, arthritis, hepatitis, and anemia. Once IBD is diagnosed, newer medical and surgical treatment modalities allow most affected children to lead relatively normal lives.

Definitions

The ultimate definition of UC and CD rests with the location and characteristics of inflammation within the gastrointestinal tract. In UC, a relatively homogeneous inflammatory process is confined to the mucosa, which starts in the rectum and involves a variable extent of colon proximally. Crypt abscesses are common. Contrary to historical belief, patients may have discontinuous inflammation at diagnosis or even rectal sparing, but over the course of the illness the inflammation becomes more confluent. Inflammation limited to the rectum, observed in 10% of patients, is termed ulcerative proctitis. In about 30% of cases, the disease is limited to the left side of the colon; in 40% to 50%, there is pancolitis.

The inflammation associated with CD may involve any portion …

Individual Login

Log in
You will be redirected to aap.org to login or to create your account.

Institutional Login

via Institution

You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.

Log in through your institution

If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.

Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00

Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.

Offer Reprints

PreviousNext
Back to top

Advertising Disclaimer »

In this issue

Pediatrics in Review: 21 (9)
Pediatrics in Review
Vol. 21, Issue 9
1 Sep 2000
  • Table of Contents
  • Cover (PDF)
  • Index by author
View this article with LENS
PreviousNext
Email Article

Thank you for your interest in spreading the word on American Academy of Pediatrics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Inflammatory Bowel Disease
(Your Name) has sent you a message from American Academy of Pediatrics
(Your Name) thought you would like to see the American Academy of Pediatrics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Request Permissions
Article Alerts
Log in
You will be redirected to aap.org to login or to create your account.
Or Sign In to Email Alerts with your Email Address
Citation Tools
Inflammatory Bowel Disease
Jeffrey S. Hyams
Pediatrics in Review Sep 2000, 21 (9) 291-295; DOI: 10.1542/pir.21-9-291

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Inflammatory Bowel Disease
Jeffrey S. Hyams
Pediatrics in Review Sep 2000, 21 (9) 291-295; DOI: 10.1542/pir.21-9-291
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Print
Download PDF
Insight Alerts
  • Table of Contents

Jump to section

  • Article
    • OBJECTIVES
    • Introduction
    • Definitions
    • Epidemiology and Genetics
    • Pathogenesis
    • Clinical Aspects
    • Diagnosis
    • Management
    • Prognosis
    • SUGGESTED READING
  • Figures & Data
  • Info & Metrics
  • Comments

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Microbial Dysbiosis in Pediatric Patients with Crohn's Disease
  • Contrast enhanced magnetic resonance imaging of the terminal ileum in children with Crohn's disease
  • Google Scholar

More in this TOC Section

  • Review of Scabies Infestation and Selected Common Cutaneous Infections
  • Pediatric Ingestions: New High-Risk Household Hazards
  • Iron Deficiency: Implications Before Anemia
Show more Articles

Similar Articles

  • Journal Info
  • Editorial Board
  • ABP Content Specifications Map
  • Overview
  • Licensing Information
  • Authors
  • Author Guidelines
  • Submit My Manuscript
  • Librarians
  • Institutional Subscriptions
  • Usage Stats
  • Support
  • Contact Us
  • Subscribe
  • Resources
  • Media Kit
  • About
  • International Access
  • Terms of Use
  • Privacy Statement
  • FAQ
  • AAP.org
  • shopAAP
  • Follow American Academy of Pediatrics on Instagram
  • Visit American Academy of Pediatrics on Facebook
  • Follow American Academy of Pediatrics on Twitter
  • Follow American Academy of Pediatrics on Youtube
American Academy of Pediatrics

© 2021 American Academy of Pediatrics